Artificial pancreas driver offers hope for type 2 …

Patients with the most common form of diabetes might experience a more comfortable time in the hospital after a successful test in controlling blood sugar levels.

The study found that people using an artificial pancreas, a closed-circuit distribution system that minimizes patient involvement in maintaining glycemic control, spent an average of 24.2% more time with blood glucose levels in the target range. .

They also had lower mean blood glucose levels, which were achieved without increasing their daily insulin dosage and without increased risk of blood sugar levels falling to dangerously low levels known as hypos, according to the research.

The artificial pancreas test was performed at the Addenbrooke Hospital in Cambridge and at another facility in the Swiss capital, Bern.

He worked by continually monitoring blood glucose levels to calculate the amount of insulin required through a device such as a tablet or mobile phone, and then administering automatically insulin through a pump.

The pilot project is considered important because most research to date has focused on the development of the artificial pancreas for people with type 1 diabetes.

The principal investigator, Dr. Roman Hovorka, of the University of Cambridge, said: "The results exceeded our expectations.

"We have not realized the difference that the artificial pancreas can do for people on insulin who stay in the hospital.

"Further research is needed to understand the broader benefits of improving blood glucose control during the hospital stay."

Type 2 diabetes occurs when the pancreas does not produce enough insulin or the body's cells do not react to insulin, which prevents the control of blood sugar levels.

Chronic disease is related to obesity, lifestyle and genetics, and is more likely to be diagnosed in older people.

The treatment involves controlling the diet or drugs, unlike type 1 diabetes, which is usually treated with insulin injections because the body does not produce any.

Dr. Elizabeth Robertson, Director of Research at Diabetes UK, said, "We know that people with type 2 diabetes are treated less well and hospitalized than people who do not have type 2 diabetes.

"Type 2 diabetes is a serious disease that needs to be managed carefully. It is therefore essential that people with this disease receive first class care at the hospital.

"This important study shows that the artificial pancreatic system could help people with type 2 diabetes manage their condition during their hospitalization by building the evidence needed to offer this type of support to people in hospitals in the future . "

The results of the trial will be published in the New England Journal of Medicine and presented at a meeting of the American Diabetes Association in Florida on Monday.